 SEATTLE, WA ACCESSWIRE June 29, 2020 Aptevo Therapeutics Inc. NASDAQ:APVO, a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIRTM bispecific ... 